BashTheBug and COVID-19 Philip Fowler, 12th April 202027th September 2021 Like many of you, the researchers behind BashTheBug have been at home for a while now due to restrictions put in place to slow the progress of this COVID-19 epidemic. There are not very many infectious disease Citizen Science projects and naturally we’ve given a lot of thought as to how we might help, but have come to the conclusion that (i) there is no compelling way a Zooniverse project could help with the epidemic, at the present time at least, and (ii) the work you all helping us fight tuberculosis by improving genetics-based diagnosis is hugely important. Let’s put it into context: the World Health Organisation estimated that around 10 million people fell ill with tuberculosis in 2018 and around 1.5 million died. At the time of writing, whilst no-one knows how many people will ultimately die as a result of being infected by this new virus, the current number was still more than 10x fewer than the number that will likely die of tuberculosis, which is treatable, during this year. So please keep classifying and if we do find a way to help, we’ll let you all know. Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Related BashTheBug on the Zooniverse News
News A closer look at microplastics! 27th August 202623rd September 2026 Recently, we visited UK Centre for Ecology & Hydrology (UKCEH) to explore the analysis of… Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Read More
News Linking life expectancy to the bacteria in our gut: A final year undergraduate project 28th August 202522nd April 2026 My name is Akika Altman-Chandler, and I just graduated from the University of Oxford with… Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Read More
We need you! 1st March 20241st March 2024 We are looking for new members to join our existing patient and public group and work with… Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Read More